Sandrine Hayette Selected Research

Sandrine Hayette Research Topics

Disease

19	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2020 - 11/2005
14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 04/2010
7	Leukemia 06/2022 - 09/2009
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2021 - 12/2008
5	Philadelphia Chromosome 11/2016 - 11/2011
4	Residual Neoplasm 01/2023 - 08/2014
4	Neoplasms (Cancer) 01/2018 - 01/2012
3	Blast Crisis (Blast Phase) 11/2011 - 01/2011
2	Acute Promyelocytic Leukemia 01/2018 - 01/2017
2	Lymphoma (Lymphomas) 01/2018 - 10/2017
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 02/2021
1	Spontaneous Abortion (Miscarriage) 12/2018
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018
1	Pathologic Complete Response 11/2016
1	Neutropenia 01/2015
1	Thrombocytopenia (Thrombopenia) 01/2015
1	Renal Insufficiency (Renal Failure) 01/2013
1	Thrombotic Thrombocytopenic Purpura 01/2013
1	Primary Myelofibrosis (Myelosclerosis) 10/2008
1	Thrombocytosis (Thrombocythemia) 10/2008
1	Necrosis 05/2004

Drug/Important Bio-Agent (IBA)

17	Imatinib Mesylate (Gleevec)FDA Link 05/2019 - 11/2005
12	Tyrosine Kinase InhibitorsIBA 01/2020 - 10/2010
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 01/2006
4	Dasatinib (BMS 354825)FDA Link 11/2016 - 09/2009
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 06/2011
3	Phosphotransferases (Kinase)IBA 01/2020 - 09/2009
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
2	nilotinib FDA Link 06/2020 - 01/2013
2	NucleotidesIBA 01/2018 - 09/2009
2	Gemtuzumab (Mylotarg)FDA Link 08/2014 - 02/2014
1	Busulfan (Busulfex)FDA Link 01/2023
1	Amsacrine (AMSA)IBA 01/2023
1	fludarabineIBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2022
1	CPX-351IBA 12/2021
1	RNA (Ribonucleic Acid)IBA 02/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2019
1	blinatumomabIBA 10/2019
1	Interferon-alpha (Interferon Alfa)IBA 12/2018
1	plerixafor FDA Link 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	ParaffinIBA 01/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2018
1	Co-Repressor ProteinsIBA 10/2017
1	Peroxidase (Myeloperoxidase)IBA 01/2017
1	Asparaginase (Elspar)FDA Link 11/2016
1	Methotrexate (Mexate)FDA LinkGeneric 11/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2015
1	Vincristine (Oncovin)FDA LinkGeneric 06/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2015
1	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2015
1	Cyclin-Dependent Kinase Inhibitor p16IBA 04/2015
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2015
1	Alanine Transaminase (SGPT)IBA 01/2015
1	ponatinibIBA 10/2013
1	IgKIBA 01/2013
1	TransferasesIBA 01/2012
1	DNA (Deoxyribonucleic Acid)IBA 01/2012
1	MethyltransferasesIBA 01/2012
1	Daunorubicin (Cerubidine)FDA LinkGeneric 06/2011
1	src-Family KinasesIBA 01/2011
1	HomoharringtonineIBA 10/2010
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2010
1	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2004

Therapy/Procedure

12	Therapeutics 01/2023 - 10/2008
5	Drug Therapy (Chemotherapy) 01/2021 - 02/2014
3	Transplantation 06/2022 - 11/2005
2	Stem Cell Transplantation 01/2017 - 11/2011
1	Hematopoietic Stem Cell Transplantation 01/2023
1	Induction Chemotherapy 01/2018
1	Homologous Transplantation 10/2013
1	Kidney Transplantation 01/2013
1	Aftercare (After-Treatment) 10/2008